(R)-2-Aminohept-6-enoic acid, 98+%, 500mg

Methyl 4-(4-bromophenyl)-2,4-dioxobutanoate, 95.0%, 1g

1,4-Dichlorobenzène, >=99%, pour la synthèse, 250 g, emballage plastique.

2,2':5',2''-Terthiophene-5,5''-dicarboxaldehyde>98.0%(GC)1g

1-Cbz-Piperazine, 98.00%, 5g

2-cyclopropyl-1H-benzimidazole, 95.0%, 250mg

2-Bromo-4,6-dichloroiodobenzene, 95.0%, 1g

4,4-Dimethyl-5-oxopentanenitrile, 95.0%, 50g

Methyl 1-methylpiperidine-2-carboxylate, 95.0%, 100g

4-Acetylamino-3-fluoro-benzenesulfonyl chloride, 95.0%, 10g

1-Tetradecyne, 98%, 1g

Salmeterol Xinafoate>98.0%(HPLC)(T)250mg

13-Bromo-1-tridecanol, 95.0%, 5g